Method for early detection, prediction of treatment response and prognosis of colorectal cancer

PH12022552766B1Active Publication Date: 2026-08-19EG BIOMED CO LTD

0 Cites 0 Cited by

Patent Information

Application Number: PH12022552766
Authority / Receiving Office: PH · PH
Patent Type: Patents
Current Assignee / Owner
Filing Date: 2022-10-18
Publication Date: 2026-08-19
Estimated Expiration: 2042-10-18

Application Information

Patent Timeline

18 Oct 2022

Application

PH12022552766

19 Aug 2026

Publication

PH12022552766B1

Inventors: LIN, Ruo-Kai; HUNG, Chin-Sheng

Get more patent work done with AI

Run novelty searches—or use them for FTO, design risk, drafting and technical problem-solving.

Explore More Agents

Novelty Search
Search existing technologies and assess novelty
↗
FTO
Analyze whether a product may infringe others' patents
↗
Design FTO
Check prior-design risk for exterior design
↗
Drafting
Draft patent application text based on a technical solution
↗
Find Solutions with TRIZ
Generate feasible solution to solve your technical challenge
↗
IP MCP Servers
Connect trusted patent search and cited evidence to Claude, Cursor or your own AI workflow
↗

Patent Text Reader

Abstract

The present disclosure discloses a set of novel epigenetic biomarkers for early detection, prediction of treatment response and prognosis of colorectal cancer. Aberrant methylation of the epigenetic biomarkers can be detected in tumor tissues and plasma samples from colorectal cancer patients but not in normal individuals. The present disclosure also discloses primers and probes used herein.

Need to check novelty before this filing date? Find Prior Art